{{Rsnum
|rsid=583134
|Gene=GOLGA1
|Chromosome=9
|position=124911921
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=T
|GMAF=0.01148
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=GOLGA1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 0.0 | 2.2 | 97.8
| JPT | 0.0 | 2.7 | 97.3
| YRI | 1.4 | 15.2 | 83.4
| ASW | 0.0 | 14.0 | 86.0
| CHB | 0.0 | 2.2 | 97.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 2.8 | 97.2
| MEX | 0.0 | 6.9 | 93.1
| MKK | 0.0 | 7.7 | 92.3
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=583134
|allele=C
|frequency=1
|uid=1103652183543
|type=homozygous_SNP
|hugo=GOLGA1
|ensembl gene=ENSG00000136935
|ensembl transcript=ENST00000373555
|sift=TOLERATED
|disease=Antibodies against GOLGA1 are present in sera from patients with Sjoegren syndrome (SS) (MIM:270150). Sera from patients with SS often contain antibodies that react with normal components of the Golgi complex.
}}

{{GET Evidence
|gene=GOLGA1
|aa_change=Leu317Val
|aa_change_short=L317V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs583134
|overall_frequency_n=10532
|overall_frequency_d=10758
|overall_frequency=0.978992
|n_genomes=56
|n_genomes_annotated=0
|n_haplomes=111
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}